McAdoo, S. P., Tanna, A., Hrušková, Z., Holm, L., Weiner, M., Arulkumaran, N., . . . Pusey, C. D. (2017). Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int.
Chicago-stil citatMcAdoo, Stephen P., et al. "Patients Double-seropositive for ANCA and Anti-GBM Antibodies Have Varied Renal Survival, frequency of Relapse, and Outcomes Compared to Single-seropositive Patients." Kidney Int 2017.
MLA-referensMcAdoo, Stephen P., et al. "Patients Double-seropositive for ANCA and Anti-GBM Antibodies Have Varied Renal Survival, frequency of Relapse, and Outcomes Compared to Single-seropositive Patients." Kidney Int 2017.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.